Insulin Management
First Claim
1. A method comprising:
- receiving blood glucose measurements of a patient at a data processing device from a glucometer, the blood glucose measurements separated by a time interval;
receiving patient information at the data processing device;
selecting, using the data processing device, a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, the subcutaneous standard program comprising;
determining a blood glucose type of the received blood glucose measurement using the data processing device; and
determining a correction insulin dose based on the blood glucose type using the data processing device by calculating;
CBx=(BGx−
BGTarget)/CF;
wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; and
executing, using the data processing device, the selected subcutaneous insulin treatment.
4 Assignments
0 Petitions
Accused Products
Abstract
A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meat subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.
10 Citations
30 Claims
-
1. A method comprising:
-
receiving blood glucose measurements of a patient at a data processing device from a glucometer, the blood glucose measurements separated by a time interval; receiving patient information at the data processing device; selecting, using the data processing device, a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, the subcutaneous standard program comprising; determining a blood glucose type of the received blood glucose measurement using the data processing device; and determining a correction insulin dose based on the blood glucose type using the data processing device by calculating;
CBx=(BGx−
BGTarget)/CF;wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; and executing, using the data processing device, the selected subcutaneous insulin treatment. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. A system comprising:
-
a glucometer measuring blood glucose measurements separated by a time interval; and a dosing controller in communication with the glucometer, the dosing controller including a data processing device and non-transitory memory in communication with the data processing device, the dosing controller; receiving blood glucose measurements of a patient from the glucometer; receiving patient information; and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, wherein during the standard subcutaneous program, the dosing controller; determines a blood glucose type of the received blood glucose measurement; and determines a correction insulin dose based on the blood glucose type by calculating;
CBx=(BGx−
BGTarget)/CF;wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; and executing the selected subcutaneous insulin treatment. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification